Structure | Chemical Name | CAS | MF |
|
5-Methoxy-1-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
|
1256360-41-4
|
C16H22BNO3
|
|
4-Methoxy-3-propoxyphenylboronic acid
|
150145-31-6
|
C10H15BO4
|
|
2-Methoxy-5-phenylphenol
|
37055-80-4
|
C13H12O2
|
|
5-(2-Methoxyethoxy)pyridine-3-boronic acid
|
1015229-31-8
|
C8H12BNO4
|
|
3-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid
|
936728-20-0
|
C14H19BO5
|
|
2-(Methoxymethoxy)-5-(trifluoromethylthio)phenylboronic acid, pinacol ester
|
2096341-93-2
|
C15H20BF3O4S
|
|
2-(4-Methoxy-2-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
1073353-81-7
|
C13H18BNO5
|
|
2-(4-Methoxybenzyloxy)-5-(trifluoromethyl)pyridine
|
1033202-62-8
|
C14H12F3NO2
|
|
2-Methoxymethoxy-5-(trifluoromethyl)phenylboronic acid
|
1256355-54-0
|
C9H10BF3O4
|
|
3-Methoxy-4-trifluoroMethylaniline
|
|
C8H8F3NO
|
|
2-Methoxybenzyl chloride
|
|
C8H9ClO
|
|
4-Methoxy-2-trifluoroMethoxynitrobenzene
|
1260770-16-8
|
C8H6F3NO4
|
|
3-Methoxybenzylphosphonic acid
|
1263034-19-0
|
C8H11O4P
|
|
6-Methoxy-4a,8a-dihydroquinazolin-4-ol
|
|
C9H10N2O2
|
|
8-Methoxyquinazoline-2,4-diol
|
|
C9H8N2O3
|
|
6-Methoxy-D-tryptophan
|
399030-99-0
|
C12H14N2O3
|
|
6-Methoxy-2,3,4,9-tetrahydro-1H-carbazol-3-aMine
|
64226-27-3
|
C13H16N2O
|
|
5-Methoxybenzofuran-2-carboxaMide
|
35351-22-5
|
C10H9NO3
|
|
5-Methoxybenzofuran-2-carbonyl chloride
|
68898-11-3
|
C10H7ClO3
|
|
(2-Methoxy-6-nitrophenyl)Methanol
|
19689-87-3
|
C8H9NO4
|
|
2-Methoxy-6-nitrobenzoyl chloride
|
33844-24-5
|
C8H6ClNO4
|
|
2-Methoxy-6-nitrobenzaMide
|
64431-77-2
|
C8H8N2O4
|
|
3-(MethoxyMethyl)-azetidine
|
942400-33-1
|
C5H11NO
|
|
4-Methoxy-1-Methoxycarbonyl-beta-carboline
|
60807-25-2
|
C14H12N2O3
|
|
15-Methoxychinensine A
|
|
|
|
8-Methoxybonducellin
|
90996-27-3
|
C18H16O5
|
|
2-Methoxystypandrone
|
85122-21-0
|
C14H12O5
|
|
3-(3-(MethoxyMethoxy)phenyl)propanal
|
53214-75-8
|
C11H14O3
|
|
1-(3-Methoxypropyl)guanidine
|
100056-66-4
|
C5H13N3O
|
|
Methotrexate Related Compound E (50 mg) (4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
|
70844-48-3
|
C15H16ClN7O2
|
|
Methoxymethylguanine (20 mg)
|
|
|
|
6-Methoxy-3-Methyl-Isoquinoline
|
14446-31-2
|
C11H11NO
|
|
Methotrexate System Suitability Mixture (5 mg)
|
|
|
|
METHOD 602 ALTERNATE BTEX STANDARD
|
|
|
|
METHOD 617 PCB SCREENING STANDARD
|
|
|
|
4-MethoxyphenethyllinoleoylaMide
|
1177258-57-9
|
C27H43NO2
|
|
3-(4-Methoxyphenyl)benzenesulfonyl chloride
|
799283-94-6
|
C13H11ClO3S
|
|
2-(2-Methoxy-2-oxoethylcarbaMoyl)pyrrolidine Trifluoroacetate
|
|
C10H15F3N2O5
|
|
5-[(3-MethoxyphenylaMino)Methylene]-2,2-diMethyl-1,3-dioxane-4,6-dione
|
213699-52-6
|
C14H15NO5
|
|
3-Methoxy-o-phenylenediaMine Hydrochloride
|
878769-98-3
|
C7H11ClN2O
|
|
2-(2-Methoxyethoxy)-3-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridine
|
1354712-71-2
|
C15H24BNO4
|
|
4-(2-Methoxyethoxy)-3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridine
|
1350636-48-4
|
C14H22BNO4
|
|
2-Methoxy-5-methylaniline Solution
|
|
C8H11NO
|
|
Methoxyfenozide Solution
|
|
|
|
Methoprene Solution
|
|
|
|
Methoprotryne Solution
|
|
|
|
Method 549 Solutions - Determination of Paraquat and Diquat
|
|
|
|
Method 549 Solutions - Determination of Paraquat and Diquate
|
|
|
|
2-Methoxy-5-nitroaniline Solution
|
|
C7H8N2O3
|
|
6-(2-METHOXY-2-OXOETHOXY)PYRIDINE-3-BORONIC ACID
|
897952-14-6
|
C8H10BNO5
|
|
5-Methoxy-1H-pyrazolo[3,4-b]pyridin-3-carboxylic acid
|
1211515-71-7
|
C8H7N3O3
|
|
2'-Methoxy-2,3',4,5'-TetraBDE
|
|
|
|
METHOD 23 SURROGATE STANDARD STOCK SOLUTION
|
|
|
|
METHOD 23 CALIBRATION STANDARD
|
|
|
|
METHOD 23 RECOVERY STANDARD STOCK SOLUTION
|
|
|
|
METHOD 23 INTERNAL STANDARD STOCK SOLUTION
|
|
|
|
METHOD 23 ALTERNATE RECOVERY STOCK SOLUTION
|
|
|
|
METHOD 23 CALIBRATION SOLUTIONS
|
|
|
|
8-METHOXY-1,2,3,4-TETRAHYDROISOQUINOLINE
|
24693-40-1
|
C10H14ClNO
|
|
5-Methoxy-1H-pyrrolo[2,3-c]pyridine-3-carbaldehyde
|
227180-23-6
|
C9H8N2O2
|
|
4-Methoxy-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde
|
1190314-48-7
|
C9H8N2O2
|
|
8-Methoxy-4-Methylquinazoline
|
69674-28-8
|
C10H10N2O
|
|
1-(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-yl)-azetidine-3-carboxylic acid
|
1353977-93-1
|
C10H13N3O3S
|
|
[(6-Methoxy-pyridazin-3-ylMethyl)-aMino]-acetic acid
|
1353970-02-1
|
C8H11N3O3
|
|
2-(3-MethoxyMethyl-piperidin-1-yl)-ethylaMine
|
1353955-61-9
|
C9H20N2O
|
|
1-(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-yl)-piperidine-3-carboxylic acid
|
1353978-49-0
|
C12H17N3O3S
|
|
4-(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-yl)-piperazine-1,3-dicarboxylic acid 1-tert-butyl ester
|
1353944-85-0
|
C16H24N4O5S
|
|
(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-yl)-piperidin-3-ylMethyl-aMine hydrochloride
|
|
C12H21ClN4OS
|
|
(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-yl)-pyrrolidin-3-yl-aMine hydrochloride
|
1353985-32-6
|
C10H17ClN4OS
|
|
1-(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-yl)-piperidin-4-ol
|
1353979-87-9
|
C11H17N3O2S
|
|
2-[(6-Methoxy-pyridazin-3-ylMethyl)-Methyl-aMino]-ethanol
|
1353961-06-4
|
C9H15N3O2
|
|
4-(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-yl)-2-Methyl-piperazine-1-carboxylic acid tert-butyl ester
|
1353985-37-1
|
C16H26N4O3S
|
|
2-(2-MethoxyMethyl-pyrrolidin-1-yl)-ethanol
|
1353957-71-7
|
C8H17NO2
|
|
2-(2-Methoxy-phenylsulfanyl)-ethanol
|
13290-20-5
|
C9H12O2S
|
|
(4-Methoxy-benzyl)-piperidin-3-yl-aMine hydrochloride
|
1353945-93-3
|
C13H21ClN2O
|
|
[1-(4-Methoxy-benzyl)-piperidin-4-yl]-Methanol
|
1455249-03-2
|
C14H21NOS
|
|
1-(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-yl)-piperidin-3-ol
|
1353958-15-2
|
C11H17N3O2S
|
|
1-(4-Methoxy-benzyl)-piperidine-2-carboxylic acid 4-Methoxy-benzyl ester
|
1353943-63-1
|
C22H27NO4
|
|
4-[(6-Methoxy-pyriMidin-4-ylaMino)-Methyl]-piperidine-1-carboxylic acid tert-butyl ester
|
1353980-28-5
|
C16H26N4O3
|
|
2-(2-MethoxyMethyl-pyrrolidin-1-yl)-ethylaMine
|
1353948-03-4
|
C8H18N2O
|
|
4-Methoxy-6-(3-Methyl-piperazin-1-yl)-pyriMidine hydrochloride
|
1353974-08-9
|
C10H17ClN4O
|
|
(2-Methoxy-phenylsulfanyl)-acetic acid
|
18619-21-1
|
C9H10O3S
|
|
(4-Methoxy-cyclohexyl)-Methyl-aMine
|
1311569-60-4
|
C8H17NO
|
|
(6-Methoxy-pyriMidin-4-yl)-piperidin-3-yl-aMine
hydrochloride
|
1353954-31-0
|
C10H17ClN4O
|
|
3-(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-ylaMino)-pyrrolidine-1-carboxylic acid tert-butyl ester
|
1353987-53-7
|
C15H24N4O3S
|
|
1-(6-Methoxy-pyriMidin-4-yl)-piperidine-3-carboxylic acid
|
1353955-34-6
|
C11H15N3O3
|
|
[1-(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-yl)-piperidin-4-yl]-Methyl-aMine hydrochloride
|
|
C12H21ClN4OS
|
|
2-(2-MethoxyMethyl-piperidin-1-yl)-ethanol
|
1353947-90-6
|
C9H19NO2
|
|
(4-Methoxy-benzyl)-piperidin-4-ylMethyl-aMine hydrochloride
|
1353955-71-1
|
C14H23ClN2O
|
|
[(6-Methoxy-pyridazin-3-ylMethyl)-Methyl-aMino]-acetic acid
|
1353951-81-1
|
C9H13N3O3
|
|
(3-Methoxy-piperidin-1-yl)-acetic acid
|
1353987-64-0
|
C8H15NO3
|
|
(6-Methoxy-pyriMidin-4-yl)-piperidin-4-yl-aMine hydrochloride
|
1353984-99-2
|
C10H17ClN4O
|
|
1-(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-yl)-[1,4]diazepane hydrochloride
|
1353958-23-2
|
C11H19ClN4OS
|
|
(6-Methoxy-pyriMidin-4-yl)-pyrrolidin-2-ylMethyl-aMine hydrochloride
|
1353980-10-5
|
C10H17ClN4O
|
|
(4-Methoxy-benzyl)-piperidin-4-yl-aMine hydrochloride
|
1353974-43-2
|
C13H21ClN2O
|
|
1-(4-Methoxy-benzyl)-3-Methyl-piperazine hydrochloride
|
1353946-24-3
|
C13H21ClN2O
|
|
1-(6-Methoxy-pyriMidin-4-yl)-piperidine-2-carboxylic acid
|
1353943-81-3
|
C11H15N3O3
|
|
[1-(6-Methoxy-pyriMidin-4-yl)-piperidin-4-yl]-Methanol
|
1353966-41-2
|
C11H17N3O2
|
|
4-[(6-Methoxy-2-Methylsulfanyl-pyriMidin-4-yl)-Methyl-aMino]-piperidine-1-carboxylic acid tert-butyl ester
|
1353987-55-9
|
C17H28N4O3S
|
|
(2-MethoxyMethyl-piperidin-1-yl)-acetic acid
|
1353961-45-1
|
C9H17NO3
|